Resources

Clinical Practice Guidelines Webinar: Tocilizumab

Product: — Science Table

Drug Interventions Healthcare Workers Models Treatments

covid19-sciencetable.ca Last Updated: April 26, 2021

Ongoing Trials for Drugs in the Prevention and Treatment of COVID-19

Product: — Canadian Agency for Drugs and Technologies in Health

Drug Interventions Treatments

covid.cadth.ca Last Updated: April 22, 2021

Also available in Français

Strategies to Manage Tocilizumab Supply During the COVID‑19 Pandemic

Product: — Science Table

Drug Interventions Future Planning Treatments

covid19-sciencetable.ca Last Updated: April 19, 2021

Clinical Practice Guideline Summary: Recommended Drugs and Biologics in Adult Patients with COVID-19

Product: — Science Table

Drug Interventions Treatments

covid19-sciencetable.ca Last Updated: April 6, 2021

Tocilizumab and Sarilumab: Evidence Review and Appraisal

Product: — Canadian Agency for Drugs and Technologies in Health

Drug Interventions Treatments

covid.cadth.ca Last Updated: March 25, 2021

Also available in Français

Casirivimab-Imdevimab for COVID-19: Evidence Review and Appraisal

Product: — Canadian Agency for Drugs and Technologies in Health

Drug Interventions Treatments

covid.cadth.ca Last Updated: March 25, 2021

Also available in Français

Interleukin‐6 blocking agents for treating COVID‐19: a living systematic review

Product: — Cochrane Library

Drug Interventions Treatments

www.cochranelibrary.com Last Updated: March 18, 2021

Also available in Français

Mobile On-Site COVID‑19 Vaccination of Naturally Occurring Retirement Communities by Neighbourhood Risk in Toronto

Product: — Science Table

Health Inequities Health Status Vaccine Vaccines & Immunity

covid19-sciencetable.ca Last Updated: March 17, 2021

Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease

Product: — Cochrane Library

Drug Interventions Treatments

www.cochranelibrary.com Last Updated: March 16, 2021

Also available in Français

COVID‐19 and its cardiovascular effects: a systematic review of prevalence studies

Product: — Cochrane Library

Health Status Vulnerable Groups

www.cochranelibrary.com Last Updated: March 11, 2021

Also available in Français